| CASE REPORT |
|
| Year : 2021 | Volume
: 10
| Issue : 2 | Page : 1034-1036 |
|
|
Bupropion-induced acute dystonia in a patient with bulimia nervosa: A case report
Parvane Rashidpour, Zahra Poursharif, Mina Ayatollahi, Elham Farzannejad
Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi, University of Medical Sciences, Yazd, Iran
Correspondence Address:
Dr. Zahra Poursharif
Department of Psychiatry, Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi, University of Medical Sciences, Yazd
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jfmpc.jfmpc_1173_20
|
|
|
Bupropion is taken as an antidepressant for treatment of major depressive disorders, treatment of sexual side effects of selective serotonin reuptake inhibitors, and as a smoking cessation aid, however, it may result in adverse effects such as nausea, dry mouth, headache, insomnia, dizziness, anxiety, tremor, and constipation. We investigate the case of a 34-year-old woman with bulimia nervosa where acute dystonia was induced by bupropion in 8 months. Following this diagnosis and after normal tests and MRI results, the patient was advised to discontinue bupropion intake. In the follow-up done 2 weeks later, 3 months later, and 6 months later, no signs of acute dystonia was observed. A physician who administers dopamine blocking agents must be aware of the prevalence of and the risk factors for acute dystonia and also the way of prevention and treatment.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
